Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas.
- Published in:
- International Journal of Endocrinology, 2019, p. 1, doi. 10.1155/2019/8516858
- By:
- Publication type:
- Article
Works matching AU Zhao, Sida
Results: 24
1
2
Development and validation of basement membrane-related signatures for predicting postoperative recurrence, tumor microenvironment and drug candidates in chordomas.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14006-1
- By:
- Publication type:
- Article
3
Decreased FOXO1 Expression Is Correlated with Poor Prognosis in Myelodysplastic Syndromes.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 6933, doi. 10.3390/curroncol29100545
- By:
- Publication type:
- Article
4
P739: INCREASED FOXO1 EXPRESSION IS ASSOCIATED WITH BETTER PROGNOSIS IN MYELODYSPLASTIC SYNDROME PATIENTS RECEIVING DECITABINE THERAPY.
- Published in:
- HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969860.06066.d2
- By:
- Publication type:
- Article
5
MiR-320a Acts as a Tumor Suppressor in Somatotroph Pituitary Neuroendocrine Tumors by Targeting BCAT1.
- Published in:
- Neuroendocrinology, 2024, v. 114, n. 1, p. 14, doi. 10.1159/000533549
- By:
- Publication type:
- Article
6
Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes.
- Published in:
- Leukemia & Lymphoma, 2024, v. 65, n. 1, p. 100, doi. 10.1080/10428194.2023.2271593
- By:
- Publication type:
- Article
7
S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2023, v. 55, n. 2, p. 194, doi. 10.3724/abbs.2023015
- By:
- Publication type:
- Article
8
Quantitative Ubiquitinomics Revealed Abnormal Ubiquitinated ATP7A Involved in Down-Regulation of ACTH in Silent Corticotroph Adenomas.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.863017
- By:
- Publication type:
- Article
9
Analysis of the Prognostic and Immunological Role of HSPB1 in Pituitary Adenoma: A Potential Target for Therapy.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 5, p. 885, doi. 10.3390/medicina59050885
- By:
- Publication type:
- Article
10
Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 2, p. 373, doi. 10.3390/medicina59020373
- By:
- Publication type:
- Article
11
Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma.
- Published in:
- Oncology Letters, 2020, v. 20, n. 1, p. 561, doi. 10.3892/ol.2020.11601
- By:
- Publication type:
- Article
12
Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2984, doi. 10.3390/cancers14122984
- By:
- Publication type:
- Article
13
Somatic SF3B1 hotspot mutation in prolactinomas.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16052-8
- By:
- Publication type:
- Article
14
The Apoptosis Regulator 14-3-3η and Its Potential as a Therapeutic Target in Pituitary Oncocytoma.
- Published in:
- Frontiers in Endocrinology, 2019, v. 10, p. 1, doi. 10.3389/fendo.2019.00797
- By:
- Publication type:
- Article
15
Integration of Proteomics and Metabolomics Revealed Metabolite–Protein Networks in ACTH-Secreting Pituitary Adenoma.
- Published in:
- Frontiers in Endocrinology, 2018, p. N.PAG, doi. 10.3389/fendo.2018.00678
- By:
- Publication type:
- Article
16
IGF-IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway.
- Published in:
- Oncology Reports, 2020, v. 44, n. 3, p. 1094, doi. 10.3892/or.2020.7652
- By:
- Publication type:
- Article
17
The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
18
CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.
- Published in:
- 2019
- By:
- Publication type:
- journal article
19
Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets.
- Published in:
- 2019
- By:
- Publication type:
- journal article
20
Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation.
- Published in:
- Scientific Reports, 2017, p. 43849, doi. 10.1038/srep43849
- By:
- Publication type:
- Article
21
Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41419-018-0552-7
- By:
- Publication type:
- Article
22
Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41419-018-0545-6
- By:
- Publication type:
- Article
23
Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutation.
- Published in:
- 2022
- By:
- Publication type:
- Letter
24
Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14‐3‐3η in oncocytomas.
- Published in:
- Journal of Pathology, 2018, v. 245, n. 3, p. 361, doi. 10.1002/path.5090
- By:
- Publication type:
- Article